Recent developments of dual-energy CT in oncology
- 2.5k Downloads
Dual-energy computed tomography (DECT) can amply contribute to support oncological imaging: the DECT technique offers promising clinical applications in oncological imaging for tumour detection and characterisation while concurrently reducing the radiation dose. Fast image acquisition at two different X-ray energies enables the determination of tissue- or material-specific features, the calculation of virtual unenhanced images and the quantification of contrast medium uptake; thus, tissue can be characterised and subsequently monitored for any changes during treatment. DECT is already widely used, but its potential in the context of oncological imaging has not been fully exploited yet. The technology is the subject of ongoing innovation and increasingly with respect to its clinical potential, particularly in oncology. This review highlights recent state-of-the-art DECT techniques with a strong emphasis on ongoing DECT developments relevant to oncologic imaging, and then focuses on clinical DECT applications, especially its prospective uses in areas of oncological imaging.
• Dual-energy CT (DECT) offers fast, robust, quantitative and functional whole-body imaging.
• DECT provides improved tumour detection and more detailed tissue differentiation and characterisation.
• DECT affords therapy monitoring with complementary information and reduced radiation dose.
• The use of DECT in oncology is of increasing clinical importance.
• The potential of DECT in oncology has not been fully exploited yet.
KeywordsComputed tomography Dual-energy CT Oncology Oncologic imaging Cancer imaging
Dual-energy computed tomography
Dual-source computed tomography
Field of measurement
Gastrointestinal stromal tumour
Magnetic resonance imaging
Non-small cell lung carcinoma
Squamous cell carcinoma
Single-photon emission computed tomography
Cooperation with Siemens AG, Germany. This includes a specific collaboration agreement with the aim of a joint collaboration in the field of CT research in oncology as well as consultancies within the Siemens Advisory Board on oncologic imaging.
- 3.Kachelrieß M (2013) Iterative reconstruction techniques: what do they mean for cardiac CT? Curr Cardiovasc Imaging Rep 6, April 2013Google Scholar
- 4.Bruder H, Raupach R, Petersilka M, Sunnegårdh J, Stierstorfer K (2011) Bi-modal CT reconstruction (BMR). Proceedings of the 2nd international conference on image formation in X-ray computed tomography, p 107–110Google Scholar
- 6.Joo I, Lee JM, Kim KW, Klotz E, Han JK, Choi BI (2011) Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response. Eur J Radiol 80:e278–e283. doi: 10.1016/j.ejrad.2010.12.002 PubMedCrossRefGoogle Scholar
- 16.Imafuji A, Hara M, Sasaki S, Arakawa T, Ozawa Y, Shibamoto Y (2012) Usefulness of dual-energy CT scanning at 80 kVp for identifying hilar and mediastinal structures: evaluation of contrast enhancement of the pulmonary vessels and lymph nodes. Jpn J Radiol 30:69–77. doi: 10.1007/s11604-011-0014-y PubMedCrossRefGoogle Scholar
- 23.Hur S, Lee JM, Kim SJ, Park JH, Han JK, Choi BI (2012) 80-kVp CT using iterative reconstruction in image space algorithm for the detection of hypervascular hepatocellular carcinoma: phantom and initial clinical experience. Korean J Radiol 13:152–164. doi: 10.3348/kjr.2012.13.2.152 PubMedCentralPubMedCrossRefGoogle Scholar
- 25.Yamada Y, Jinzaki M, Tanami Y, Abe T, Kuribayashi S (2012) Virtual monochromatic spectral imaging for the evaluation of hypovascular hepatic metastases: the optimal monochromatic level with fast kilovoltage switching dual-energy computed tomography. Investig Radiol 47:292–298. doi: 10.1097/RLI.0b013e318240a874 CrossRefGoogle Scholar
- 26.Uhrig M, Sedlmair M, Schlemmer HP, Hassel JC, Ganten M (2013) Monitoring targeted therapy using dual energy CT: semiautomatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastases. Cancer Imaging 13:306–313. doi: 10.1102/1470-7330.2013.0031 PubMedCrossRefGoogle Scholar
- 27.Dai X, Schlemmer HP, Schmidt B et al (2013) Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. Eur J Radiol 82:327–334. doi: 10.1016/j.ejrad.2012.11.013 PubMedCrossRefGoogle Scholar
- 30.Marin D, Nelson RC, Barnhart H et al (2010) Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique–preliminary results. Radiology 256:450–459. doi: 10.1148/radiol.10091819 PubMedCrossRefGoogle Scholar